Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline M Moore

Showing results (171-180 of 231) with videos related to

Pageof 24
Sort By:
JNCI Cancer Spectrum|May 16, 2025
Disparities in Tissue-based Biomarker Testing Among U.S. Medicare Beneficiaries with Prostate CancerStephan M Korn, Zhiyu Qian, Hanna Zurl, et al.
The Journal of Urology|July 19, 2018
Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE TrialLucy A M Simmons, Abi Kanthabalan, Manit Arya, et al.
Radiology|April 15, 2025
Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naive Men: PI-RADS Steering Committee, Version 1.0Baris Turkbey, Henkjan Huisman, Andriy Fedorov, et al.
The Journal of Urology|February 8, 2019
Pathological Findings and Magnetic Resonance Imaging Concordance at Salvage Radical Prostatectomy for Local Recurrence following Partial Ablation Using High Intensity Focused UltrasoundJames Edward Thompson, Ashwin N Sridhar, Wei Shen Tan, et al.
European Urology|March 9, 2016
Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry CohortLouise Dickinson, Manit Arya, Naveed Afzal, et al.
BMJ Oncology|January 31, 2025
Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: a prospective cohort studyCaroline M Moore, Elena Frangou, Neil McCartan, et al.
Prostate Cancer and Prostatic Diseases|November 23, 2024
Combining tissue biomarkers with mpMRI to diagnose clinically significant prostate cancer. Analysis of 21 biomarkers in the PICTURE studyUrszula Stopka-Farooqui, Vasilis Stavrinides, Benjamin S Simpson, et al.
European Urology Open Science|January 13, 2022
Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) ConsortiumJonathan Olivier, Weiyu Li, Daan Nieboer, et al.
European Radiology|February 19, 2026
Diagnostic accuracy of a 'stage-gated' approach for reporting prostate screening MRI: "Is less more?"Natasha Thorley, Tom Parry, Giorgio Brembilla, et al.
World Journal of Urology|July 9, 2020
Focal HIFU therapy for anterior compared to posterior prostate cancer lesionsPhilipp M Huber, Naveed Afzal, Manit Arya, et al.
Pageof 24

Showing results (171-180 of 231) with videos related to

Sort By:
Pageof 24
JNCI Cancer Spectrum|May 16, 2025
Disparities in Tissue-based Biomarker Testing Among U.S. Medicare Beneficiaries with Prostate CancerStephan M Korn, Zhiyu Qian, Hanna Zurl, et al.
The Journal of Urology|July 19, 2018
Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE TrialLucy A M Simmons, Abi Kanthabalan, Manit Arya, et al.
Radiology|April 15, 2025
Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naive Men: PI-RADS Steering Committee, Version 1.0Baris Turkbey, Henkjan Huisman, Andriy Fedorov, et al.
The Journal of Urology|February 8, 2019
Pathological Findings and Magnetic Resonance Imaging Concordance at Salvage Radical Prostatectomy for Local Recurrence following Partial Ablation Using High Intensity Focused UltrasoundJames Edward Thompson, Ashwin N Sridhar, Wei Shen Tan, et al.
European Urology|March 9, 2016
Medium-term Outcomes after Whole-gland High-intensity Focused Ultrasound for the Treatment of Nonmetastatic Prostate Cancer from a Multicentre Registry CohortLouise Dickinson, Manit Arya, Naveed Afzal, et al.
BMJ Oncology|January 31, 2025
Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: a prospective cohort studyCaroline M Moore, Elena Frangou, Neil McCartan, et al.
Prostate Cancer and Prostatic Diseases|November 23, 2024
Combining tissue biomarkers with mpMRI to diagnose clinically significant prostate cancer. Analysis of 21 biomarkers in the PICTURE studyUrszula Stopka-Farooqui, Vasilis Stavrinides, Benjamin S Simpson, et al.
European Urology Open Science|January 13, 2022
Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) ConsortiumJonathan Olivier, Weiyu Li, Daan Nieboer, et al.
European Radiology|February 19, 2026
Diagnostic accuracy of a 'stage-gated' approach for reporting prostate screening MRI: "Is less more?"Natasha Thorley, Tom Parry, Giorgio Brembilla, et al.
World Journal of Urology|July 9, 2020
Focal HIFU therapy for anterior compared to posterior prostate cancer lesionsPhilipp M Huber, Naveed Afzal, Manit Arya, et al.
Pageof 24